Doctors and researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, are making encouraging inroads in the treatment of melanoma, the deadliest form of skin cancer.
Melanoma News
Clinical Perspectives: Single-Agent Vs Combination Immunotherapy for Melanoma
Panelists discuss how monotherapy may still be appropriate for certain patient populations including those with desmoplastic melanoma, solid organ transplants, severe autoimmune disease, and older patients where the toxicity risk of combination therapy may outweigh benefits.
Who should be screened for skin cancer?
Skin cancer is the most common cancer in the U.S. More than 6 million adults are treated for it each year, says Dr. Michael Colgan, a Mayo Clinic Health System dermatologist in Eau Claire, Wisconsin.
Q&A: Changes in moles during pregnancy should not be ignored
Research suggests the impact of pregnancy on melanoma risk remains unclear.